Le Lézard
Classified in: Health, Business
Subjects: NPT, NAT

Blue Cross Blue Shield of Massachusetts Expedites Access to Care for New York Members Affected by Blizzard


BOSTON, Dec. 28, 2022 /PRNewswire/ -- In response to the blizzard that struck New York, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who live in affected communities.  

Blue Cross has more than 3,000 members in the impacted areas in New York. The company is working to ensure those members can access health services and medications quickly and in locations convenient to them. 

Effective December 27, 2022 until January 27, 2023, Blue Cross is allowing:

(Note: Only members with Blue Cross' telehealth benefit will be able to access Well Connection and only via My Blue)

About Blue Cross Blue Shield of Massachusetts

Blue Cross Blue Shield of Massachusetts (bluecrossma.org) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We are committed to the relentless pursuit of quality, equitable and affordable health care with an unparalleled consumer experience. Consistent with our promise to always put our members first, we are rated among the nation's best health plans for member satisfaction and quality. Connect with us on FacebookTwitterYouTube, and LinkedIn.

SOURCE Blue Cross Blue Shield of Massachusetts


These press releases may also interest you

at 18:00
Aurora Cannabis Inc. ("Aurora" or the "Company") , the Canadian company opening the world to cannabis, today announced receipt of a notification letter (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated March 24, 2023,...

at 17:30
Cybeats Technologies Corp. ("Cybeats'' or the "Company") is pleased to announce the commencement of a trial evaluation with one of the top-3 largest software companies by total revenue, for Cybeats SBOM Studio.1...

at 17:30
Western University of Health Sciences' College of Osteopathic Medicine of the Pacific (COMP) and COMP-Northwest celebrated 100% residency placement on Match Day, compared to the averages across all other medical schools with match rates of 91.6% for...

at 17:00
Andlauer Healthcare Group Inc. ("AHG" or the "Company") today announced that the Toronto Stock Exchange has approved its notice of intention to make a normal course issuer bid for a portion of its subordinate voting shares ("Shares") as appropriate...

at 17:00
Pieris Pharmaceuticals, Inc. ,a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that it will host...

at 16:35
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for the full year ended December 31, 2022, and provided a corporate...



News published on 28 december 2022 at 10:35 and distributed by: